surufatinib

US Bridging Study Not Enough as FDA Denies Hutchmed's Pancreatic Cancer Drug
BioSpace
Mon, 05/2/22 - 06:32 pm
FDA
Hutchmed
pancreatic cancer
surufatinib
Chi-Med stops pivotal pancreatic cancer trial upon early success
Fierce Biotech
Tue, 01/21/20 - 11:56 am
Chi-Med
clinical trials
surufatinib
pancreatic cancer
ESMO: Eyeing Novartis and Pfizer, Chi-Med touts neuroendocrine cancer win
Fierce Pharma
Mon, 09/30/19 - 10:38 am
Chi-Med
surufatinib
Pfizer
Sutent
Novartis
Afinitor
Lutathera
neuroendocrine tumors. ESMO
Chi-Med Halts Phase III Study Early After Meeting Primary Endpoint
BioSpace
Fri, 06/14/19 - 06:20 pm
Chi-Med
neuroendocrine tumors
clinical trials
surufatinib